Literature DB >> 578762

[Structure-activity relationships of etozolin, a novel diuretic (author's transl)].

G Satzinger.   

Abstract

Selection of a structurally confined group of diuretics out of 2-methylenethiazolidones-(4), a new class of compounds, and related heterocycles with partly choleretic properties is described. The physico-chemical parameters of ethyl (Z)-(3-methyl-4-oxo-5-piperidino-thiazolidin-2-ylidene) acetate (3; etozolin, Gö 687, Elkapin), which has been selected for therapeutic use, are discussed with respect to its close structural relation to the choleretic piprozoline (2). Both the spectroscopic results and the anomalous thermodynamic data of 2, 3 and the homologous compounds 4 and 5 demonstrate a structural specificity of 3 unknown up to now with diuretics.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 578762

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


  5 in total

1.  Effects of ozolinone, a diuretic active metabolite of etozoline, on renal function. II. Localization of tubular site of diuretic action by micropuncture in the rat.

Authors:  J Greven; H Klein; O Heidenreich
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-10       Impact factor: 3.000

Review 2.  Clinical pharmacokinetics of some newer diuretics.

Authors:  B Beermann; M Grind
Journal:  Clin Pharmacokinet       Date:  1987-10       Impact factor: 6.447

3.  Pharmacodynamics and kinetics of etozolin/ozolinone in hypertensive patients with normal and impaired kidney function.

Authors:  H Knauf; R Liebig; P Schollmeyer; J Rosenthal; E U Kölle; E Mutschler
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

4.  Placental transfer of etozolin and ozolinone during the first half of gestation in man.

Authors:  H Nau; R Steldinger; E Ivan
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

5.  Effects of ozolinone, a diuretic active metabolite of etozoline, on renal function. I. Clearance studies in dogs.

Authors:  J Greven; O Heidenreich
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-10       Impact factor: 3.000

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.